1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Atherotech

Anonymous board for Atherotech

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    101
    Views:
    33,608
  2. anonymous
    Replies:
    0
    Views:
    1,557
  3. anonymous
    Replies:
    0
    Views:
    1,870
  4. anonymous
    Replies:
    3
    Views:
    3,092
  5. anonymous
    Replies:
    5
    Views:
    3,663
  6. anonymous
    Replies:
    20
    Views:
    5,981
  7. anonymous
    Replies:
    2
    Views:
    1,850
  8. anonymous
    Replies:
    8
    Views:
    3,518
  9. anonymous
    Replies:
    10
    Views:
    2,949
  10. Happy from Ningbo China
    Replies:
    2
    Views:
    1,919
  11. anonymous
    Replies:
    2
    Views:
    1,879
  12. anonymous
    Replies:
    3
    Views:
    1,850
  13. anonymous
    Replies:
    4
    Views:
    1,745
  14. anonymous
    Replies:
    5
    Views:
    1,676
  15. anonymous
    Replies:
    6
    Views:
    1,866
  16. anonymous
    Replies:
    37
    Views:
    7,949
  17. anonymous
    Replies:
    37
    Views:
    8,319
  18. anonymous
    Replies:
    1
    Views:
    3,621
  19. anonymous
    Replies:
    2
    Views:
    2,126
  20. anonymous
    Replies:
    12
    Views:
    2,401

Thread Display Options

Loading...